Acurx Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.33
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.27
|
0.00
|
0.27
|
100.00%
|
|
2022-12-31
|
-0.31
|
0.00
|
0.31
|
100.00%
|
|
2022-09-30
|
-0.28
|
-0.32
|
-0.04
|
-14.29%
|
|
2022-06-30
|
-0.33
|
-0.26
|
0.07
|
21.21%
|
|
2022-03-31
|
-0.33
|
-0.26
|
0.07
|
21.21%
|
|
2021-12-31
|
-0.40
|
-0.22
|
0.18
|
45.00%
|
|
2021-09-30
|
-0.46
|
-0.21
|
0.25
|
54.35%
|
|
2021-06-30
|
0.00
|
-0.57
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.84
|
|
2021-12-31
|
-1.48
|
|
2020-12-31
|
-0.47
|